BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 17681353)

  • 1. Cleft-type cyclophanes confer neuroprotection against excitatory neurotoxicity in vitro and in vivo through inhibition of NMDA receptors.
    Masuko T; Nemoto Y; Nagaoka H; Miyake M; Kizawa Y; Kusama-Eguchi K; Kashiwagi K; Igarashi K; Kusama T
    Neuropharmacology; 2007 Sep; 53(4):515-23. PubMed ID: 17681353
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuroprotection by tosyl-polyamine derivatives through the inhibition of ionotropic glutamate receptors.
    Masuko T; Namiki R; Nemoto Y; Miyake M; Kizawa Y; Suzuki T; Kashiwagi K; Igarashi K; Kusama T
    J Pharmacol Exp Ther; 2009 Nov; 331(2):522-30. PubMed ID: 19644042
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cyclophane and acyclic cyclophane: novel channel blockers of N-methyl-D-aspartate receptor.
    Masuko T; Nagaoka H; Miyake M; Metori K; Kizawa Y; Kashiwagi K; Igarashi K; Kusama T
    Neurochem Int; 2007 Jan; 50(2):443-9. PubMed ID: 17113196
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential effects of linear and cyclic polyamines on NMDA receptor activities.
    Masuko T; Miyake M; Kusama-Eguchi K; Koike T; Kimura E; Kizawa Y; Kashiwagi K; Igarashi K; Kusama T
    Neurochem Int; 2008 Jul; 53(1-2):38-44. PubMed ID: 18556092
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antagonism of NMDA receptors by butanesulfonyl-homospermine guanidine and neuroprotective effects in in vitro and in vivo.
    Masuko T; Suzuki T; Miyake M; Kusama-Eguchi K; Kizawa Y; Tomono K; Kashiwagi K; Igarashi K; Kusama T
    Neurosci Lett; 2012 Jan; 506(2):251-5. PubMed ID: 22119002
    [TBL] [Abstract][Full Text] [Related]  

  • 6. NMDA preconditioning protects against seizures and hippocampal neurotoxicity induced by quinolinic acid in mice.
    Boeck CR; Ganzella M; Lottermann A; Vendite D
    Epilepsia; 2004 Jul; 45(7):745-50. PubMed ID: 15230696
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular interactions of the type 1 human immunodeficiency virus transregulatory protein Tat with N-methyl-d-aspartate receptor subunits.
    Chandra T; Maier W; König HG; Hirzel K; Kögel D; Schüler T; Chandra A; Demirhan I; Laube B
    Neuroscience; 2005; 134(1):145-53. PubMed ID: 15964699
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protective effect of donepezil in primary-cultured rat cortical neurons exposed to N-methyl-d-aspartate (NMDA) toxicity.
    Akasofu S; Kimura M; Kosasa T; Ogura H; Sawada K
    Eur J Pharmacol; 2006 Jan; 530(3):215-22. PubMed ID: 16406045
    [TBL] [Abstract][Full Text] [Related]  

  • 9. GMP prevents excitotoxicity mediated by NMDA receptor activation but not by reversal activity of glutamate transporters in rat hippocampal slices.
    Molz S; Tharine DC; Decker H; Tasca CI
    Brain Res; 2008 Sep; 1231():113-20. PubMed ID: 18655777
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Monoamines directly inhibit N-methyl-D-aspartate receptors expressed in Xenopus oocytes in a voltage-dependent manner.
    Masuko T; Suzuki I; Kizawa Y; Kusama-Eguchi K; Watanabe K; Kashiwagi K; Igarashi K; Kusama T
    Neurosci Lett; 2004 Nov; 371(1):30-3. PubMed ID: 15500961
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacological characterization of Ro 63-1908 (1-[2-(4-hydroxy-phenoxy)-ethyl]-4-(4-methyl-benzyl)-piperidin-4-ol), a novel subtype-selective N-methyl-D-aspartate antagonist.
    Gill R; Alanine A; Bourson A; Buttelmann B; Fischer G; Heitz MP; Kew JN; Levet-Trafit B; Lorez HP; Malherbe P; Miss MT; Mutel V; Pinard E; Roever S; Schmitt M; Trube G; Wybrecht R; Wyler R; Kemp JA
    J Pharmacol Exp Ther; 2002 Sep; 302(3):940-8. PubMed ID: 12183650
    [TBL] [Abstract][Full Text] [Related]  

  • 12. beta-estradiol, dehydroepiandrosterone, and dehydroepiandrosterone sulfate protect against N-methyl-D-aspartate-induced neurotoxicity in rat hippocampal neurons by different mechanisms.
    Kurata K; Takebayashi M; Morinobu S; Yamawaki S
    J Pharmacol Exp Ther; 2004 Oct; 311(1):237-45. PubMed ID: 15175425
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Possible protection by notoginsenoside R1 against glutamate neurotoxicity mediated by N-methyl-D-aspartate receptors composed of an NR1/NR2B subunit assembly.
    Gu B; Nakamichi N; Zhang WS; Nakamura Y; Kambe Y; Fukumori R; Takuma K; Yamada K; Takarada T; Taniura H; Yoneda Y
    J Neurosci Res; 2009 Jul; 87(9):2145-56. PubMed ID: 19224577
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative effects of levobupivacaine and racemic bupivacaine on excitotoxic neuronal death in culture and N-methyl-D-aspartate-induced seizures in mice.
    Marganella C; Bruno V; Matrisciano F; Reale C; Nicoletti F; Melchiorri D
    Eur J Pharmacol; 2005 Aug; 518(2-3):111-5. PubMed ID: 16043171
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuroprotective properties of memantine in different in vitro and in vivo models of excitotoxicity.
    Volbracht C; van Beek J; Zhu C; Blomgren K; Leist M
    Eur J Neurosci; 2006 May; 23(10):2611-22. PubMed ID: 16817864
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of NMDA-gated ion channels by bis(7)-tacrine: whole-cell and single-channel studies.
    Liu YW; Luo JL; Ren H; Peoples RW; Ai YX; Liu LJ; Pang YP; Li ZW; Han YF; Li CY
    Neuropharmacology; 2008 Jun; 54(7):1086-94. PubMed ID: 18407299
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synergism between NMDA and domoic acid in a murine model of behavioural neurotoxicity.
    Tasker RA; Strain SM
    Neurotoxicology; 1998; 19(4-5):593-7. PubMed ID: 9745916
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis of a novel water-soluble cleft-type cyclophane as an N-methyl-D-aspartate receptor antagonist.
    Masuko T; Kusama T; Namiki R; Metori K; Kizawa Y; Miyake M
    Chem Pharm Bull (Tokyo); 2009 Jan; 57(1):95-8. PubMed ID: 19122326
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Guanine nucleotides inhibit NMDA and kainate-induced neurotoxicity in cultured rat hippocampal and neocortical neurons.
    Morciano M; Ortinau S; Zimmermann H
    Neurochem Int; 2004 Jul; 45(1):95-101. PubMed ID: 15082227
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of the pharmacological properties of GK11 and MK801, two NMDA receptor antagonists: towards an explanation for the lack of intrinsic neurotoxicity of GK11.
    Vandame D; Desmadryl G; Becerril Ortega J; Teigell M; Crouzin N; Buisson A; Privat A; Hirbec H
    J Neurochem; 2007 Nov; 103(4):1682-96. PubMed ID: 17908242
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.